Brief: Telesis Bio Releases BioXp® Select mRNA Synthesis Kit
16/02/2023 14:12
Feb 16 (Reuters) - Telesis Bio Inc TBIO.O :
* TELESIS BIO RELEASES BIOXP® SELECT MRNA SYNTHESIS KIT TO
EXPAND
THE UTILITY, SPEED, AND IMPACT OF ITS AUTOMATED SYNTHETIC
BIOLOGY WORKSTATION
Source text for Eikon: ID:nGNX3cLzQF
Further company coverage: TBIO.O
((Reuters.briefs@thomsonreuters.com;))
Recent news on Telesis Bio
See all newsBrief: Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
Brief: Telesis Bio Plans To Delist Its Securities From The Nasdaq Stock Market
Brief: Telesis Bio Says Co Entered Share Purchase Agreement With Yuan Yang To Sell All Of Outstanding Capital Stock Of Eton Bio
Telesis Bio Inc reports results for the quarter ended in June - Earnings Summary
Telesis Bio Inc expected to post a loss of $4.03 a share - Earnings Preview